Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective
Aims: Peripheral artery disease affects 1.2% of the population globally and is associated with an increased risk of atherothrombotic cardiovascular events, major adverse limb events and mortality. The Cardiovascular Outcomes for People Using Anti-coagulation Strategies (COMPASS) trial demonstrated p...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Sage Publications
2018
|
| Online Access: | http://hdl.handle.net/20.500.11937/74837 |